Jean Van Wyk, ViiV Healthcare
ViiV HealthcareJean van Wyk (MB,ChB; MFPM) is the Global Medical Lead for Dolutegravir in ViiV Healthcare, based in Brentford (UK). He obtained his medical degree in 1999 (South Africa) and completed specialist training in Pharmaceutical Medicine with the Royal College in 2011 (UK).
Presenter Of 1 Presentation
Oral abstract session
OAB0606 - Improved metabolic parameters after switching from TAF-based 3- or 4-drug regimen to the 2-drug regimen of DTG/3TC (dolutegravir/lamivudine): The TANGO study
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Improved metabolic parameters after switching from TAF-based 3- or 4-drug regimen to the 2-drug regimen of DTG/3TC (dolutegravir/lamivudine): The TANGO study
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
Improved metabolic parameters after switching from TAF-based 3- or 4-drug regimen to the 2-drug regimen of DTG/3TC (dolutegravir/lamivudine): The TANGO study
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel